Impaired NK-cell migration in WAS/XLT patients: Role of Cdc42/WASp pathway in the control of chemokine-induced β2 integrin high-affinity state

Blood

Volumn 115, Issue 14, 2010, Pages 2818-2826

  Stabile, Helena ^a   Carlino, Claudia ^a   Mazza, Cinzia ^b   Giliani, Silvia ^b   Morrone, Stefania ^a   Notarangelo, Lucia D ^c   Notarangelo, Luigi D ^b,d   Santoni, Angela ^a   Gismondi, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Spedali Civili of Brescia   (Italy)

^c SPEDALI CIVILI   (Italy)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA1 INTEGRIN; BETA2 INTEGRIN; CD18 ANTIGEN; CHEMOKINE RECEPTOR; CXCL1 CHEMOKINE; EPITOPE; FOCAL ADHESION KINASE 2; FRACTALKINE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PROTEIN CDC42; PROTEIN KINASE FYN; STROMAL CELL DERIVED FACTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CYTOSKELETON; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WISKOTT ALDRICH SYNDROME;

EID: 77951020111     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-235804     Document Type: Article

References (49)

1. Thrasher AJ. WASp in immune-system organization and function. Nat Rev Immunol. 2002;2(9): 635-646.
2. Badour K, Zhang J, Siminovitch KA. The Wiskott-Aldrich syndrome protein: forging the link between actin and cell activation. Immunol Rev. 2003;192:98-112. (Pubitemid 36613326)
3. Villa A, Notarangelo L, Macchi P, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9(4):414-417.
4. Zhu Q, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression and phenotype. Blood. 1997;90(7):2680-2689. (Pubitemid 27413478)
5. Ochs HD, Rosen FS. The Wiskott-Aldrich syndrome. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: A Molecular and Genetics Approach. New York, NY: Oxford University Press; 1999:292-305.
6. Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol. 2008; 15(1):30-36.
7. Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 2000;404(6774):151-158. (Pubitemid 30154475)
8. Oda A, Ochs HD, Druker BJ, et al. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. Blood. 1998;92(6):1852-1858. (Pubitemid 28446673)
9. Guinamard R, AspenstromP, Fougereau M, Chavrier P, Guillemot JC. Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by CDC42. FEBS Lett. 1998;434(3):431-436. (Pubitemid 29052271)
10. Baba Y, Nonoyama S, Matsushita M, et al. Involvement of Wiskott-Aldrich protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 1999; 93(6):2003-2012.
11. Badour K, Zhang J, Shi F, Leng Y, Collins M, Siminovitch KA. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J Exp Med. 2004;199(1):99-112. (Pubitemid 38076482)
12. Orange JS, Ramesh N, Remold-O'Donnell E, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002;99(17):11351-11356. (Pubitemid 34920929)
13. Gismondi A, Cifaldi L, Mazza C, et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood. 2004;104(2): 436-443.
14. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009;31(1):15-23.
15. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol. 2008;8(4): 259-268.
16. Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003;101(8):3052-3057.
17. King A, Burrows T, Loke YW. Human uterine natural killer cells. Nat Immun. 1996-1997;15(1):41-52. (Pubitemid 27042056)
18. Biron CA. Activation and function of natural killer cell responses during viral infection. Curr Opin Immunol. 1997;9(1):24-34. (Pubitemid 27098860)
19. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol. 1996;156(12):4707-4714. (Pubitemid 26174454)
20. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol. 2002;2(12):957-964. (Pubitemid 37323216)
21. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76(2):301-314.
22. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 2002;16(1):1-4.
23. Timonen T. Natural killer cells: endothelial interactions, migration and target cell recognition. J Leukoc Biol. 1997;62(6):693-701. (Pubitemid 28015616)
24. Gismondi A, Santoni A. Migration of NK cells. In: Badolato R, Sozzani S, eds. Lymphocyte Trafficking in Health and Disease. Basel, Switzerland: Birkhauser Verlag; 2006:95-112.
25. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15: 675-705.
26. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999; 20(6):254-257. (Pubitemid 29258161)
27. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18: 217-242.
28. Ley K, Laudanna C, Cybulsky MI, Noushargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678-689. (Pubitemid 47327397)
29. Barreiro O, de la Fuente H, Mittelbrunn M, Sanchez-Madrid F. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol Rev. 2007;218:147-164. (Pubitemid 47052299)
30. Badolato R, Sozzani S, Malacarne F, et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol. 1998;161(2):1026-1033.
31. Zicha D, Allen WE, Brickell PM, et al. Chemotaxis of macrophages is abolished in the Wiskott- Aldrich syndrome. Br J Haematol. 1998;101(4): 659-665.
32. Haddad E, Zugaza JL, Louache F, et al. The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood. 2001;97(1):33-38.
33. Westerberg L, Larsson M, Hardy SJ, Fernández C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005; 105(3):1144-1152.
34. De Noronha S, Hardy S, Sinclair J, et al. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein. Blood. 2005; 105(4):1590-1597.
35. Snapper SB, Meelu P, Nguyen D, et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol. 2005;77(6):993-998.
36. Giliani S, Fiorini M, Mella P, et al. Prenatal molecular diagnosis of Wiskott-Aldrich syndrome by direct mutation analysis. Prenat Diagn. 1999; 19(1):36-40. (Pubitemid 29054600)
37. Lupher ML Jr, Harris EA, Beals CR, Sui LM, Liddington RC, Staunton DE. Cellular activation of leukocyte function-associated antigen-1 and its affinity are regulated at the I domain allosteric site. J Immunol. 2001;167(3):1431-1439.
38. Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat Immun Cell Growth Regul. 1987; 6(4):171-188. (Pubitemid 18083744)
39. Gismondi A, Jacobelli J, Strippoli R, et al. Prolinerich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. J Immunol. 2003; 170(6):3065-3073. (Pubitemid 36302181)
40. Cory GO, Garg R, Cramer R, Ridley AJ. Phosphorylation of tyrosine 291 enhances the ability of WASP to stimulate actin polymerization and filopodium formation. J Biol Chem. 2002;277(47): 45115-45121. (Pubitemid 36159113)
41. Tsuboi S, Meerloo J. Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages. J Biol Chem. 2007; 282(47):34194-34203. (Pubitemid 350159472)
42. Chellaiah MA, Kuppuswamy D, Lasky L, Linder S. Phosphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption. J Biol Chem. 2007; 282(13):10104-10116. (Pubitemid 47104634)
43. Peterson JR, Bickford LC, Morgan D, et al. Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol. 2004;11(8):747-755. (Pubitemid 39014500)
44. Gallego MD, de la Fuente MA, Anton IM, Snapper S, Fuhlbrigge R, Geha RS. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha. Int Immunol. 2006;18(2): 221-232.
45. Zhang H, Schaff UY, Green CE, et al. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity. 2006;25(2):285-295.
46. Tsuboi S, Nonoyama S, Ochs HD. Wiskott-Aldrich syndrome protein is involved in alphaIIb beta3-mediated cell adhesion. EMBO Rep. 2006;7(5): 506-511.
47. Mukai Y, Iwaya K, Ogawa H, Mukai K. Involvement of Arp2/3 complex in MCP-1-induced chemotaxis. Biochem Biophys Res Commun. 2005; 334(2):395-402. (Pubitemid 40982381)
48. Andreev J, Galisteo ML, Kranenburg O, et al. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J Biol Chem. 2001;276(23):20130-20135.
49. Qian D, Lev S, van Oers NS, Dikic I, Schlessinger J, Weiss A. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J Exp Med. 1997;185(7):1253-1259..